Susquehanna International Group’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-15,357
| Closed | -$93K | – | 11346 |
|
|
2019
Q4 | $93K | Sell |
15,357
-57,180
| -79% | -$331K | ﹤0.01% | 9168 |
|
|
2019
Q3 | $261K | Sell |
72,537
-67,247
| -48% | -$259K | ﹤0.01% | 8607 |
|
|
2019
Q2 | $375K | Buy |
+139,784
| New | +$413K | ﹤0.01% | 7872 |
|
|
2019
Q1 | – | Sell |
-98,696
| Closed | -$242K | – | 10360 |
|
|
2018
Q4 | $156K | Buy |
98,696
+77,456
| +365% | +$219K | ﹤0.01% | 7954 |
|
|
2018
Q3 | $78K | Sell |
21,240
-112,801
| -84% | -$336K | ﹤0.01% | 8696 |
|
|
2018
Q2 | $379K | Buy |
134,041
+32,141
| +32% | +$109K | ﹤0.01% | 7379 |
|
|
2018
Q1 | $378K | Sell |
101,900
-104,834
| -51% | -$343K | ﹤0.01% | 7202 |
|
|
2017
Q4 | $595K | Buy |
206,734
+191,896
| +1,293% | +$697K | ﹤0.01% | 6307 |
|
|
2017
Q3 | $67K | Sell |
14,838
-23,711
| -62% | -$105K | ﹤0.01% | 8475 |
|
|
2017
Q2 | $177K | Sell |
38,549
-171,165
| -82% | -$688K | ﹤0.01% | 8381 |
|
|
2017
Q1 | $883K | Buy |
209,714
+83,886
| +67% | +$348K | ﹤0.01% | 5389 |
|
|
2016
Q4 | $520K | Buy |
125,828
+103,271
| +458% | +$549K | ﹤0.01% | 6899 |
|
|
2016
Q3 | $183K | Buy |
+22,557
| New | +$192K | ﹤0.01% | 7645 |
|
|
2016
Q2 | – | Sell |
-122,620
| Closed | -$1.05M | – | 9685 |
|
|
2016
Q1 | $947K | Sell |
122,620
-70,243
| -36% | -$514K | ﹤0.01% | 5202 |
|
|
2015
Q4 | $2.08M | Sell |
192,863
-445,125
| -70% | -$4.05M | ﹤0.01% | 3958 |
|
|
2015
Q3 | $4.41M | Sell |
637,988
-3,813
| -0.6% | -$31.1K | ﹤0.01% | 2860 |
|
|
2015
Q2 | $5.69M | Sell |
641,801
-50,976
| -7% | -$482K | ﹤0.01% | 2718 |
|
|
2015
Q1 | $6.83M | Buy |
692,777
+572,687
| +477% | +$7.15M | ﹤0.01% | 2310 |
|
|
2014
Q4 | $1.47M | Sell |
120,090
-40,524
| -25% | -$495K | ﹤0.01% | 5078 |
|
|
2014
Q3 | $1.6M | Buy |
160,614
+13,522
| +9% | +$126K | ﹤0.01% | 5020 |
|
|
2014
Q2 | $1.11M | Sell |
147,092
-248,175
| -63% | -$990K | ﹤0.01% | 5818 |
|
|
2014
Q1 | $1.3M | Buy |
395,267
+149,460
| +61% | +$523K | ﹤0.01% | 5055 |
|
|
2013
Q4 | $816K | Sell |
245,807
-521,453
| -68% | -$1.51M | ﹤0.01% | 5849 |
|
|
2013
Q3 | $2.32M | Buy |
767,260
+3,530
| +0.5% | +$24.2K | ﹤0.01% | 3868 |
|
|
2013
Q2 | $6.25M | Buy |
+763,730
| New | +$5.83M | ﹤0.01% | 2338 |
|
Susquehanna International Group's ACHN Position: Q1 2020 in Review
Susquehanna International Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 15,357 shares — an estimated $93K sold.
Susquehanna International Group first reported a position in ACHN in Q2 2013 and held it in 25 quarters. The position peaked at $6.83M in Q1 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Susquehanna International Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Susquehanna International Group sold 15,357 Achillion Pharmaceuticals shares in Q1 2020, an estimated $93K.
- Susquehanna International Group first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 25 quarters.
- Susquehanna International Group's Achillion Pharmaceuticals position peaked at $6.83M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.